about
Cerebrospinal fluid biomarkers of Alzheimer’s diseaseBiological markers of amyloid beta-related mechanisms in Alzheimer's diseaseBiomarkers of Alzheimer's diseaseA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersAmyloid-β and Astrocytes Interplay in Amyloid-β Related DisordersA review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalusThe past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular eventsAlzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studiesPreanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationThe potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseBrain imaging in Alzheimer diseaseClinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersPrimary progressive aphasia and the evolving neurology of the language networkCerebrospinal fluid and blood biomarkers in Alzheimer's diseaseMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseHarnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and ChallengesThe corticobasal syndrome-Alzheimer's disease conundrumPrediction of cognitive decline in healthy older adults using fMRIFunctional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease riskA Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's DiseaseMultiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosisThe diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseImaging plus X: multimodal models of neurodegenerative disease.Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's DiseaseA data-driven model of biomarker changes in sporadic Alzheimer's disease.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.CSF biomarkers for mild cognitive impairment.Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.Use of fuzzy edge single-photon emission computed tomography analysis in definite Alzheimer's disease--a retrospective study.Biomarkers in the diagnosis of Alzheimer's disease: are we ready?Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.Biomarkers for early detection of Alzheimer pathology.Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations.A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia.Biomarkers in translational research of Alzheimer's diseaseAlzheimer DiseaseCurrent Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.
P2860
Q22252572-800120C5-9C75-4B11-A943-53BFB35002B9Q24622136-CAF9F271-A816-4C9E-94DF-BFD81CFFBF36Q24650667-D731AAF2-CF53-444E-BB72-05C250BC6391Q26745508-245DDD6C-D390-4493-AA15-E0E434DC1A9FQ26766934-030CE7E9-CECA-4362-86E5-AAB37085540DQ26771308-7A65F6DF-9F0C-487D-BD2E-AB9F3D4EC589Q26781635-FF8C4296-A9D4-4346-8490-9DB29A6A8A6CQ26798325-F695E0D2-C43F-4566-BE01-0015D71BA8CDQ26801663-87F4554D-28A8-49E4-9666-A086A9B2A694Q26853347-E3902DF3-348E-4F55-9EF2-E59080C414F3Q26996299-E107BCB6-DBA2-4E20-B8C7-6145F803C41DQ27008249-2050BC95-FE7D-4A9A-B2CC-E3DA2753199EQ27011657-02BF7D3B-33B2-41E7-9766-CD9A1824B3D7Q27023758-E901E7DC-DD62-4D5D-A2E9-29461505B88BQ27027319-18A3A152-72AE-4A56-AD81-F74DEBA42A46Q28072061-694A0095-CCBF-4D26-9FE3-FB7A63224175Q28250881-4C13C660-CA22-465A-B5EC-9B546BD89AFAQ28383378-15B52206-332D-4D80-B4A5-10C0DCCDD5CEQ28394799-165C465E-4AAE-4953-8B03-A8208506B83AQ28547333-ECC9303C-6BEB-43F0-9663-62AFF81E1B13Q28740917-04E40C93-35AC-4AC7-A57B-6D479A63A20EQ29614406-A37173AC-EF03-4553-A2E7-E54BA1C68A38Q30491715-7DFBBA4A-F639-4A2A-BE25-B54F1BBC3063Q30659251-192290F9-3922-4230-B66A-5FFFC8F4F9DAQ30835966-FD958CC7-81C3-4B09-8147-F749B78A9142Q30845482-D1B45321-A8F7-41BB-8868-060CB594CF10Q30871982-EF65847E-3768-42D1-9731-3A0AF0D91C23Q30953185-F7ABFC11-FC62-4704-A050-B75C2EB749EDQ30988163-791E4C67-D7C4-4F63-B0BF-EB85EBC20A4BQ30988714-53F4D2C2-43A4-4D80-A0CC-7A9D13443C7FQ31050728-C743AA9D-227D-4F87-9DA6-07A6BAA53908Q31108280-F5D90C64-4AEF-4D81-9A97-3C53763EFBE3Q31140680-1A6955BC-1351-42E9-AB7C-B3E483E02295Q31142230-2A77F228-5144-4AF4-8BDB-85C892AB0521Q33274612-1DB65F84-75CC-43FF-A79D-4FC912313AC2Q33282300-A9BEA924-92D7-405D-A5DB-C74525F1D172Q33304417-15E940BB-8577-4A5E-8A73-EDBAC8D999D2Q33556189-DBC2ECD4-9C13-467F-894E-D1A5CF331E19Q33562441-DDF3AD6F-7098-4A4C-801D-5C2CD84D2E42Q33590723-6E46FD8C-0C76-4A69-B244-E3D56E5E0125
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
CSF markers for incipient Alzheimer's disease.
@ast
CSF markers for incipient Alzheimer's disease.
@en
type
label
CSF markers for incipient Alzheimer's disease.
@ast
CSF markers for incipient Alzheimer's disease.
@en
prefLabel
CSF markers for incipient Alzheimer's disease.
@ast
CSF markers for incipient Alzheimer's disease.
@en
P1433
P1476
CSF markers for incipient Alzheimer's disease.
@en
P304
P356
10.1016/S1474-4422(03)00530-1
P577
2003-10-01T00:00:00Z